Drug Type Small molecule drug |
Synonyms CU 00048, CU00048 |
Target |
Action blockers |
Mechanism CACNA1H blockers(calcium voltage-gated channel subunit alpha1 H blockers) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Amyotrophic Lateral Sclerosis | Preclinical | United States | 01 Jun 2026 | |
| Pain | Preclinical | United States | 01 Jun 2026 | |
| Parkinson Disease | Preclinical | United States | 01 Jun 2026 | |
| Epilepsy | Preclinical | United States | 30 Jul 2024 | |
| Essential Tremor | Preclinical | United States | 30 Jul 2024 |





